These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8808231

  • 1. IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation.
    Coppo R, Amore A, Cirina P, Messina M, Basolo B, Segoloni G, Berthoux F, Boulharouz R, Egido J, Alcazar R.
    Nephrol Dial Transplant; 1995 Dec; 10(12):2310-5. PubMed ID: 8808231
    [Abstract] [Full Text] [Related]

  • 2. Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study.
    Coppo R, Amore A, Gianoglio B, Porcellini MG, Peruzzi L, Gusmano R, Giani M, Sereni F, Gianviti A, Rizzoni G.
    Clin Nephrol; 1995 Jan; 43(1):1-13. PubMed ID: 7697930
    [Abstract] [Full Text] [Related]

  • 3. [IgA serology in idiopathic IgA deposit nephropathy in children].
    Coppo R, Amore A, Gianoglio B, Porcellini MG, Peruzzi L, Reyna A, Gusmano R, Giani M, Sereni F, Gianviti A.
    Minerva Urol Nefrol; 1994 Mar; 46(1):49-54. PubMed ID: 8036552
    [Abstract] [Full Text] [Related]

  • 4. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    Garnier AS, Duveau A, Demiselle J, Croué A, Subra JF, Sayegh J, Augusto JF.
    PLoS One; 2018 Mar; 13(4):e0196101. PubMed ID: 29694420
    [Abstract] [Full Text] [Related]

  • 5. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 6. Serologic study of immunoglobulin A-fibronectin aggregates in immunoglobulin A nephropathy.
    Lai KN, To WY, Leung JC, Yu AW, Li PK.
    Am J Kidney Dis; 1996 May; 27(5):622-30. PubMed ID: 8629620
    [Abstract] [Full Text] [Related]

  • 7. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
    Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS.
    Transplant Proc; 2017 Apr; 49(3):541-545. PubMed ID: 28340830
    [Abstract] [Full Text] [Related]

  • 8. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Apr; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 9. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 10. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [Abstract] [Full Text] [Related]

  • 11. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A, Kawanishi K, Horita S, Koike J, Honda K, Ochi A, Komoda M, Tanaka Y, Unagami K, Okumi M, Shimizu T, Ishida H, Tanabe K, Nagashima Y, Nitta K.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
    [Abstract] [Full Text] [Related]

  • 12. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ, van Kooten C, de Fijter JW, Daha MR.
    Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
    [Abstract] [Full Text] [Related]

  • 13. [Serum IgA-fibronectin complex in children with various renal diseases].
    Sakai Y, Inaba S, Matsukura H, Okada T.
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1130-6. PubMed ID: 7815745
    [Abstract] [Full Text] [Related]

  • 14. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
    van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
    [Abstract] [Full Text] [Related]

  • 15. Recurrent mesangial IgA nephritis following renal transplantation.
    Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ.
    Nephrol Dial Transplant; 1994 Oct; 9(3):309-12. PubMed ID: 8052439
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells.
    Chen HC, Guh JY, Chang JM, Lai YH.
    Nephron; 2001 Jul; 88(3):211-7. PubMed ID: 11423751
    [Abstract] [Full Text] [Related]

  • 17. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
    Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T.
    Nephrology (Carlton); 2018 Jul 30; 23 Suppl 2():4-9. PubMed ID: 29968406
    [Abstract] [Full Text] [Related]

  • 19. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
    Coppo R, Amore A, Chiesa M, Lombardo F, Cirina P, Andrulli S, Passerini P, Conti G, Peruzzi L, Giraudi R, Messina M, Segoloni G, Ponticelli C.
    Clin Transplant; 2007 Jul 30; 21(6):728-37. PubMed ID: 17988266
    [Abstract] [Full Text] [Related]

  • 20. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.